SDC1 and antiphospholipid syndrome: Miranda and colleagues identified a correlation between cIMT and syndecan-1 levels in patients with antiphospholipid syndrome.41 Conversely, in the current study, a negative correlation was observed between cIMT and syndecan-1 levels.